GlassScriptPhysician profile
Keith L Kruithoff
NPI 1093825317
$3,353.29
in general payments reported to CMS, 2019-2025
23 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $325 · 2021: $723 · 2022: $317 · 2023: $258 · 2024: $196 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $637.01 | 2019-2025 | Watchman Flx, Mylux Patient Kit With Mobile Device, Vigilant X4 Crt-D |
| Abiomed | $489.38 | 2019-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $312.06 | 2019-2025 | Lifevest |
| Abbott Laboratories | $310.01 | 2021-2023 | Mitraclip, Dragonfly Opstar, Gallant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.60 | 2019-2022 | |
| Opsens INC. | $258.95 | 2019-2021 | |
| Medtronic Vascular, INC. | $256.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $203.35 | 2019-2022 | |
| Cvrx, INC. | $182.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $165.18 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $56.32 | 2023-2024 | Xarelto |
| Teleflex LLC | $30.87 | 2019-2025 | Trapliner |
| Lexicon Pharmaceuticals, INC. | $30.73 | 2024 | |
| Shockwave Medical, INC | $28.38 | 2025 | |
| Philips North America LLC | $19.56 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $16.21 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.49 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.11 | 2021 | |
| Medtronic, INC. | $14.30 | 2021 | |
| Biotronik INC. | $14.16 | 2021 | |
| Impulse Dynamics (USA) INC. | $14.04 | 2023 | Optimizer |
| Elutia, INC. | $11.01 | 2023 | |
| Cardiovascular Systems INC. | $9.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Kruithoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.